Skip to main content
Top
Published in: Journal of Neurology 11/2020

Open Access 01-11-2020 | Myotonic Dystrophy | Original Communication

Change over time in ability to perform activities of daily living in myotonic dystrophy type 1

Authors: Erik Landfeldt, Nikoletta Nikolenko, Cecilia Jimenez-Moreno, Sarah Cumming, Darren G. Monckton, Catharina G. Faber, Ingemar S. J. Merkies, Grainne Gorman, Chris Turner, Hanns Lochmüller

Published in: Journal of Neurology | Issue 11/2020

Login to get access

Abstract

Objective

The objective of this longitudinal, observational study was to investigate change over time in ability to perform activities of daily living in myotonic dystrophy type 1 (DM1).

Methods

Adults with genetically confirmed DM1 were recruited as part of the PhenoDM1 study in the UK. Data on activities of daily living were recorded through the DM1-ActivC at baseline and a follow-up visit after 12 (± 3) months. A subset of patients had advanced genetic testing to determine the size of the progenitor allele.

Results

Our sample comprised 150 patients with DM1 (mean age: 45 years; 52% female). Mean follow-up was 383 days. Mean DM1-ActivC total score at baseline was 71.24 (95% confidence interval 67.77–74.71) and at the follow-up visit 69.04 (65.54–72.54). Approximately 43% of patients had a lower score at the follow-up visit (indicating a decreased ability to perform activities of daily living), 24% a higher score (indicating an increased ability), and 33% the same score at baseline and follow-up. The mean annual change in the DM1-ActivC total score, estimated at − 2.06 (− 3.54 to − 0.59), was significantly related to patients’ baseline score, but not sex, disease duration, timed test results, or cytosine-thymine-guanine repeat length.

Conclusions

Change over time in ability to perform activities of daily living as recorded through the DM1-ActivC varies substantially between patients with DM1. Our data contribute to the understanding of the natural evolution of the disease, and should be helpful to inform the design of future trials based on the DM1-ActivC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Harper PS (2001) Myotonic dystrophy, 3rd edn. W.B. Saunders, London Harper PS (2001) Myotonic dystrophy, 3rd edn. W.B. Saunders, London
2.
go back to reference Laberge L, Mathieu J, Auclair J et al (2013) Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol 70(5–6):308–315PubMedCrossRef Laberge L, Mathieu J, Auclair J et al (2013) Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol 70(5–6):308–315PubMedCrossRef
3.
go back to reference Bouchard JP, Cossette L, Bassez G, Puymirat J (2015) Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases. J Neurol 262(2):285–293PubMedCrossRef Bouchard JP, Cossette L, Bassez G, Puymirat J (2015) Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases. J Neurol 262(2):285–293PubMedCrossRef
5.
go back to reference Hobart JC, Cano SJ, Zajicek JP et al (2007) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 6:1094–1105PubMedCrossRef Hobart JC, Cano SJ, Zajicek JP et al (2007) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 6:1094–1105PubMedCrossRef
6.
go back to reference Hermans MC, Faber CG, De Baets MH, de Die-Smulders CE, Merkies IS (2010) Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ). Neuromuscul Disord 20(5):310–318PubMedCrossRef Hermans MC, Faber CG, De Baets MH, de Die-Smulders CE, Merkies IS (2010) Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ). Neuromuscul Disord 20(5):310–318PubMedCrossRef
8.
go back to reference Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S et al (2018) Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol 17(8):671–680PubMedCrossRef Okkersen K, Jimenez-Moreno C, Wenninger S, Daidj F, Glennon J, Cumming S et al (2018) Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial. Lancet Neurol 17(8):671–680PubMedCrossRef
9.
go back to reference Rasch G (1960) Probabilistic models for some intelligence and attainment tests (1st Edition). Danish Institute for Education Research, Copenhagen Rasch G (1960) Probabilistic models for some intelligence and attainment tests (1st Edition). Danish Institute for Education Research, Copenhagen
10.
go back to reference Wright B (1997) A history of social science and measurement. Educ Meas 52:33–52 Wright B (1997) A history of social science and measurement. Educ Meas 52:33–52
11.
go back to reference Hobart J, Cano S (2009) Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13(12):1–177CrossRef Hobart J, Cano S (2009) Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13(12):1–177CrossRef
12.
go back to reference Morales F, Couto JM, Higham CF et al (2012) Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum Mol Genet 21:3558–3567PubMedCrossRef Morales F, Couto JM, Higham CF et al (2012) Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Hum Mol Genet 21:3558–3567PubMedCrossRef
13.
go back to reference Gomes-Pereira M, Bidichandani SI, Monckton DG (2004) Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Method Mol Biol 277:61–76 Gomes-Pereira M, Bidichandani SI, Monckton DG (2004) Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Method Mol Biol 277:61–76
14.
go back to reference Monckton DG, Wong L-JC, Ashizawa T, Caskey CT (1995) Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet 4(1):1–8PubMedCrossRef Monckton DG, Wong L-JC, Ashizawa T, Caskey CT (1995) Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet 4(1):1–8PubMedCrossRef
16.
go back to reference Symonds T, Randall JA, Campbell P (2017) Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients. Muscle Nerve 56(1):86–92PubMedCrossRef Symonds T, Randall JA, Campbell P (2017) Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients. Muscle Nerve 56(1):86–92PubMedCrossRef
Metadata
Title
Change over time in ability to perform activities of daily living in myotonic dystrophy type 1
Authors
Erik Landfeldt
Nikoletta Nikolenko
Cecilia Jimenez-Moreno
Sarah Cumming
Darren G. Monckton
Catharina G. Faber
Ingemar S. J. Merkies
Grainne Gorman
Chris Turner
Hanns Lochmüller
Publication date
01-11-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 11/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09970-6

Other articles of this Issue 11/2020

Journal of Neurology 11/2020 Go to the issue